{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:11:31Z","timestamp":1790395891709,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.antiviral.2013.12.005","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T11:00:42Z","timestamp":1387969242000},"page":"106-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Antiviral strategies for hepatitis E virus"],"prefix":"10.1016","volume":"102","author":[{"given":"Yannick","family":"Debing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.12.005_b0005","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/AAC.00957-12","article-title":"Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase","volume":"56","author":"Adedeji","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.12.005_b0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/viro.2000.0819","article-title":"The 3\u2032 end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp)","volume":"282","author":"Agrawal","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.12.005_b0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3201\/eid1906.130275","article-title":"Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012","volume":"19","author":"Ahmed","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0020","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1128\/JVI.00433-12","article-title":"A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells","volume":"86","author":"Ali","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-153-2-201007200-00256","article-title":"Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy","volume":"153","author":"Alric","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1096-9071(200003)60:3<275::AID-JMV5>3.0.CO;2-9","article-title":"Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1)","volume":"60","author":"Ansari","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0035","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.32.11.1742","article-title":"Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus","volume":"32","author":"Baba","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.12.005_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000149370","article-title":"Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route","volume":"20","author":"Balayan","year":"1983","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2013.12.005_b0045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.antiviral.2013.06.001","article-title":"Development of specific dengue virus 2\u2032-O- and N7-methyltransferase assays for antiviral drug screening","volume":"99","author":"Barral","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/095632020501600206","article-title":"Geldanamycin, a potent and specific inhibitor of Hsp90, inhibits gene expression and replication of human cytomegalovirus","volume":"16","author":"Basha","year":"2005","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2013.12.005_b0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virusres.2011.03.019","article-title":"A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii)","volume":"158","author":"Batts","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jmv.21656","article-title":"A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries","volume":"82","author":"Bendall","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3201\/eid1902.121255","article-title":"Hepatitis E virus in pork liver sausage, France","volume":"19","author":"Berto","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jviromet.2012.10.017","article-title":"Replication of hepatitis E virus in three-dimensional cell culture","volume":"187","author":"Berto","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2013.12.005_b0075","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/JVI.79.6.3429-3437.2005","article-title":"Systematic pathogenesis and replication of avian hepatitis E virus in specific-pathogen-free adult chickens","volume":"79","author":"Billam","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0080","first-page":"147","article-title":"Antibody targeting of TSG101 on influenza-infected cells","volume":"2010","author":"Bonavia","year":"2010","journal-title":"Virus Adapt. Treat."},{"key":"10.1016\/j.antiviral.2013.12.005_b0085","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jhep.2010.08.037","article-title":"High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome","volume":"54","author":"Bose","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-3148.2006.00652.x","article-title":"Transfusion-transmitted hepatitis E in a \u201cnonhyperendemic\u201d country","volume":"16","author":"Boxall","year":"2006","journal-title":"Transfus. Med. (Oxford, England)"},{"key":"10.1016\/j.antiviral.2013.12.005_b0095","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/AAC.01362-06","article-title":"Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins","volume":"51","author":"Bugatti","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.12.005_b0100","first-page":"581","article-title":"Investigation of hepatitis E outbreak among refugees \u2013 Upper Nile, South Sudan, 2012\u20132013","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2013.12.005_b0105","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1128\/JVI.00403-08","article-title":"The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response","volume":"82","author":"Chandra","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0110","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1128\/JVI.01994-09","article-title":"The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex","volume":"84","author":"Chandra","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0115","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/092986710790514444","article-title":"TSG101: a novel anti-HIV-1 drug target","volume":"17","author":"Chen","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.12.005_b0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.antiviral.2012.12.012","article-title":"Selective inhibition of the West Nile virus methyltransferase by nucleoside analogs","volume":"97","author":"Chen","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0125","doi-asserted-by":"crossref","first-page":"e51616","DOI":"10.1371\/journal.pone.0051616","article-title":"Rabbit as a novel animal model for hepatitis E virus infection and vaccine evaluation","volume":"7","author":"Cheng","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2013.12.005_b0130","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nchembio.370","article-title":"Rational design of small-molecule inhibitors of the LEDGF\/p75-integrase interaction and HIV replication","volume":"6","author":"Christ","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0135","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3201\/eid1304.061387","article-title":"Transfusion-associated hepatitis E, France","volume":"13","author":"Colson","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcv.2009.06.002","article-title":"Hepatitis E in an HIV-infected patient","volume":"45","author":"Colson","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0145","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/655898","article-title":"Pig liver sausage as a source of hepatitis E virus transmission to humans","volume":"202","author":"Colson","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4269\/ajtmh.1996.54.559","article-title":"A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam","volume":"54","author":"Corwin","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2013.12.005_b0155","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0160","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMc0903778","article-title":"Persistent carriage of hepatitis E virus in patients with HIV infection","volume":"361","author":"Dalton","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0165","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/MEG.0b013e32834ca4da","article-title":"Host risk factors and autochthonous hepatitis E infection","volume":"23","author":"Dalton","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.7326\/0003-4819-155-7-201110040-00017","article-title":"Treatment of chronic hepatitis E in a patient with HIV infection","volume":"155","author":"Dalton","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"1665\u20131672","key":"10.1016\/j.antiviral.2013.12.005_b0175","first-page":"e1","article-title":"Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury","volume":"141","author":"Davern","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2013.12.005_b0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.juro.2007.08.170","article-title":"Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial","volume":"179","author":"Davis","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.01795-13","article-title":"Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon","volume":"58","author":"Debing","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.12.005_b0190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coviro.2013.03.001","article-title":"Intervention strategies for emerging viruses: use of antivirals","volume":"3","author":"Debing","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.antiviral.2013.07.013","article-title":"Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication","volume":"100","author":"Debing","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0200","first-page":"368","article-title":"TSG101 exposure on the surface of HIV-1 infected cells: implications for monoclonal antibody therapy for HIV\/AIDS","volume":"2","author":"Diaz","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0205","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.25530","article-title":"Suppression of interferon-\u03b1 signaling by hepatitis E virus","volume":"55","author":"Dong","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.antiviral.2013.12.005_b0210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","article-title":"A genetically humanized mouse model for hepatitis C virus infection","volume":"474","author":"Dorner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.12.005_b0215","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1128\/JVI.00800-12","article-title":"Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae","volume":"86","author":"Drexler","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0220","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1086\/654801","article-title":"Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances","volume":"51","author":"Drobeniuc","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0225","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1128\/JVI.00713-06","article-title":"Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains","volume":"80","author":"Egloff","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0230","doi-asserted-by":"crossref","first-page":"15270","DOI":"10.1073\/pnas.251555098","article-title":"Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element","volume":"98","author":"Emerson","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0235","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1128\/JVI.00892-06","article-title":"ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro","volume":"80","author":"Emerson","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0240","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1099\/vir.0.82613-0","article-title":"Detection and characterization of infectious Hepatitis E virus from commercial pig livers sold in local grocery stores in the USA","volume":"88","author":"Feagins","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijfoodmicro.2007.11.068","article-title":"Inactivation of infectious hepatitis E virus present in commercial pig livers sold in local grocery stores in the United States","volume":"123","author":"Feagins","year":"2008","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0250","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/jmv.21223","article-title":"Cross-species infection of specific-pathogen-free pigs by a genotype 4 strain of human hepatitis E virus","volume":"80","author":"Feagins","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clineuro.2008.09.005","article-title":"Neuralgic amyotrophy associated with hepatitis E virus","volume":"111","author":"Fong","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.antiviral.2013.12.005_b0260","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jhep.2012.08.003","article-title":"Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial","volume":"57","author":"Furusyo","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-3542(91)90031-L","article-title":"Antiviral activity of sulfated polysaccharides against African swine fever virus","volume":"15","author":"Garc\u00eda-Villal\u00f3n","year":"1991","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(01)00506-2","article-title":"Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding","volume":"107","author":"Garrus","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2013.12.005_b0275","doi-asserted-by":"crossref","first-page":"e56762","DOI":"10.1371\/journal.pone.0056762","article-title":"Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus","volume":"8","author":"Geller","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2013.12.005_b0280","doi-asserted-by":"crossref","first-page":"e56320","DOI":"10.1371\/journal.pone.0056320","article-title":"Virus host protein interaction network analysis reveals that the HEV ORF3 protein may interrupt the blood coagulation process","volume":"8","author":"Geng","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2013.12.005_b0285","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcv.2011.06.004","article-title":"Treatment of severe acute hepatitis E by ribavirin","volume":"52","author":"Gerolami","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0290","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.3201\/eid1912.130521","article-title":"Hepatitis e and lymphocytic leukemia in man, Italy","volume":"19","author":"Giordani","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0295","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1128\/JVI.79.11.6680-6689.2005","article-title":"The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques","volume":"79","author":"Graff","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0300","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1128\/JVI.00046-06","article-title":"A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus","volume":"80","author":"Graff","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0305","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1073\/pnas.0904848106","article-title":"Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding","volume":"106","author":"Guu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0310","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.22014","article-title":"Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b","volume":"16","author":"Haagsma","year":"2010","journal-title":"Liver Transpl."},{"key":"10.1016\/j.antiviral.2013.12.005_b0315","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.antiviral.2011.07.006","article-title":"Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses","volume":"91","author":"Haasbach","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0320","doi-asserted-by":"crossref","first-page":"e22673","DOI":"10.1371\/journal.pone.0022673","article-title":"First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium","volume":"6","author":"Hakze-van der Honing","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2013.12.005_b0325","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/JCM.39.3.918-923.2001","article-title":"Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human","volume":"39","author":"Halbur","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0330","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.05909-11","article-title":"Structural basis for norovirus inhibition and fucose mimicry by citrate","volume":"86","author":"Hansman","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0335","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1099\/0022-1317-82-10-2449","article-title":"Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States","volume":"82","author":"Haqshenas","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0340","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1099\/vir.0.83308-0","article-title":"Putative receptor-binding sites of hepatitis E virus","volume":"89","author":"He","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0345","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1139\/f91-014","article-title":"A small RNA virus isolated from Salmonid Fishes in California, USA","volume":"48","author":"Hedrick","year":"1991","journal-title":"Can. J. Fish Aquat. Sci."},{"key":"10.1016\/j.antiviral.2013.12.005_b0350","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3354\/dao020111","article-title":"Induction of protection from infectious hematopoietic necrosis virus in rainbow trout Oncorhynchus mykiss by pre-exposure to the avirulent cutthroat trout virus (CTV)","volume":"20","author":"Hedrick","year":"1994","journal-title":"Dis. Aquat. Organ."},{"key":"10.1016\/j.antiviral.2013.12.005_b0355","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0033-1338110","article-title":"Molecular virology of hepatitis E virus","volume":"33","author":"Holla","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0365","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2334-9-93","article-title":"Experimental infection of Balb\/c nude mice with Hepatitis E virus","volume":"9","author":"Huang","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0935","unstructured":"ICTV, http:\/\/www.ictvonline.org\/virusTaxonomy.asp."},{"key":"10.1016\/j.antiviral.2013.12.005_b0370","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcv.2009.01.005","article-title":"Indigenous hepatitis E virus infection in England: more common than it seems","volume":"44","author":"Ijaz","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0375","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1093\/cid\/cit291","article-title":"Genotype 4 hepatitis e virus in france: an autochthonous infection with a more severe presentation","volume":"57","author":"Jeblaoui","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0380","first-page":"471","article-title":"HSP90 inhibitors for cancer therapy and overcoming drug resistance","volume":"65","author":"Jhaveri","year":"2012","journal-title":"Adv. Pharmacol. (San Diego, Calif.)"},{"key":"10.1016\/j.antiviral.2013.12.005_b0385","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3201\/eid1609.100444","article-title":"Novel hepatitis E virus genotype in Norway rats, Germany","volume":"16","author":"Johne","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0390","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","article-title":"A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus","volume":"131","author":"Jothikumar","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2013.12.005_b0395","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.antiviral.2010.03.004","article-title":"Efficacy of 2\u2032-C-methylcytidine against yellow fever virus in cell culture and in a hamster model","volume":"86","author":"Julander","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0400","doi-asserted-by":"crossref","first-page":"12714","DOI":"10.1128\/JVI.00717-09","article-title":"Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection","volume":"83","author":"Kalia","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0405","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","article-title":"Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients","volume":"8","author":"Kamar","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2013.12.005_b0410","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0415","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfq282","article-title":"Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient","volume":"25","author":"Kamar","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.antiviral.2013.12.005_b0420","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1600-6143.2010.03068.x","article-title":"Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis","volume":"10","author":"Kamar","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2013.12.005_b0425","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/650488","article-title":"Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation","volume":"50","author":"Kamar","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0430","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","article-title":"Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection","volume":"139","author":"Kamar","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2013.12.005_b0435","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2013.12.005_b0440","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e318245f14c","article-title":"Hepatitis E virus and the kidney in solid-organ transplant patients","volume":"93","author":"Kamar","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2013.12.005_b0445","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2893.2011.01559.x","article-title":"Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis","volume":"19","author":"Kapur","year":"2012","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2013.12.005_b0450","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1128\/JVI.00492-10","article-title":"RNA 5\u2032-triphosphatase activity of the hepatitis E virus helicase domain","volume":"84","author":"Karpe","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0455","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1128\/JVI.02130-09","article-title":"NTPase and 5\u2032\u20133\u2032 RNA duplex-unwinding activities of the hepatitis E virus helicase domain","volume":"84","author":"Karpe","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0460","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1099\/vir.0.033738-0","article-title":"Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease","volume":"92","author":"Karpe","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0465","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1128\/JVI.07039-11","article-title":"Hepatitis E virus replication requires an active ubiquitin-proteasome system","volume":"86","author":"Karpe","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0470","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.06711-11","article-title":"The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release","volume":"86","author":"Kenney","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0475","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9343(80)90200-4","article-title":"Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type","volume":"68","author":"Khuroo","year":"1980","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0480","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9343(81)90758-0","article-title":"Incidence and severity of viral hepatitis in pregnancy","volume":"70","author":"Khuroo","year":"1981","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0485","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(95)90761-0","article-title":"Vertical transmission of hepatitis E virus","volume":"345","author":"Khuroo","year":"1995","journal-title":"Lancet"},{"issue":"Pt. 9","key":"10.1016\/j.antiviral.2013.12.005_b0490","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1099\/0022-1317-72-9-2197","article-title":"The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses","volume":"72","author":"Koonin","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0495","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1073\/pnas.89.17.8259","article-title":"Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses","volume":"89","author":"Koonin","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0500","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd1853","article-title":"Viral and cellular RNA helicases as antiviral targets","volume":"4","author":"Kwong","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2013.12.005_b0505","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0510","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.08.006","article-title":"Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses","volume":"69","author":"Lee","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0515","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3201\/eid1112.051041","article-title":"Hepatitis E virus transmission from wild boar meat","volume":"11","author":"Li","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0520","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1292\/jvms.70.1359","article-title":"Mice are not susceptible to hepatitis E virus infection","volume":"70","author":"Li","year":"2008","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.antiviral.2013.12.005_b0525","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jmv.21573","article-title":"Experimental infection of Mongolian gerbils by a genotype 4 strain of swine hepatitis E virus","volume":"81","author":"Li","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0530","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3201\/eid1908.130200","article-title":"No evidence for hepatitis E virus genotype 3 susceptibility in rats","volume":"19","author":"Li","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0535","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.vetmic.2012.12.014","article-title":"Susceptibility of laboratory rats against genotypes 1, 3, 4, and rat hepatitis E viruses","volume":"163","author":"Li","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0540","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1128\/JVI.75.14.6249-6255.2001","article-title":"Virus-specific mRNA capping enzyme encoded by hepatitis E virus","volume":"75","author":"Magden","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0545","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1099\/vir.0.19587-0","article-title":"Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995","volume":"85","author":"Maila","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0550","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-153-2-201007200-00257","article-title":"Brief communication: case reports of ribavirin treatment for chronic hepatitis E","volume":"153","author":"Mallet","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0555","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/gut.2005.076646","article-title":"Treating viral hepatitis C: efficacy, side effects, and complications","volume":"55","author":"Manns","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2013.12.005_b0560","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcv.2008.09.010","article-title":"Acute hepatitis E in south-west France over a 5-year period","volume":"44","author":"Mansuy","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0565","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/AAC.05908-11","article-title":"In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses","volume":"56","author":"Marschall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.12.005_b0570","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm1201-1313","article-title":"HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress","volume":"7","author":"Martin-Serrano","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0575","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.510270331","article-title":"Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E virus antibody serum panel evaluation group","volume":"27","author":"Mast","year":"1998","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.antiviral.2013.12.005_b0580","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1073\/pnas.94.18.9860","article-title":"A novel virus in swine is closely related to the human hepatitis E virus","volume":"94","author":"Meng","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0585","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1128\/JVI.72.12.9714-9721.1998","article-title":"Genetic and experimental evidence for cross-species infection by swine hepatitis E virus","volume":"72","author":"Meng","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0590","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.20657","article-title":"Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera","volume":"41","author":"Meuleman","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.antiviral.2013.12.005_b0595","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1872-034X.2012.01006.x","article-title":"Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: zoonotic food-borne transmission of hepatitis E virus and public health concerns","volume":"42","author":"Miyashita","year":"2012","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0600","doi-asserted-by":"crossref","first-page":"21124","DOI":"10.1074\/jbc.M701696200","article-title":"The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death","volume":"282","author":"Moin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.12.005_b0605","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.micinf.2012.10.003","article-title":"Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle","volume":"15","author":"Murakami","year":"2013","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2013.12.005_b0610","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1099\/vir.0.035378-0","article-title":"Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions","volume":"92","author":"Nagashima","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0615","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1099\/vir.0.025791-0","article-title":"A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells","volume":"92","author":"Nagashima","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0620","first-page":"597","article-title":"A large waterborne viral hepatitis E epidemic in Kanpur, India","volume":"70","author":"Naik","year":"1992","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2013.12.005_b0625","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cid\/cit224","article-title":"Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin","volume":"57","author":"Neukam","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0630","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jmb.2008.10.045","article-title":"Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites","volume":"385","author":"Neuvonen","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0635","article-title":"HEV genotype 1 infection of swine kidney cells in vitro is inhibited at multiple levels","author":"Nguyen","year":"2013","journal-title":"J. Virol"},{"key":"10.1016\/j.antiviral.2013.12.005_b0640","first-page":"60","article-title":"Progesterone supplementation and the prevention of preterm birth","volume":"4","author":"Norwitz","year":"2011","journal-title":"Rev. Obstet. Gynecol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0645","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2013.109309","article-title":"Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial","volume":"310","author":"Osinusi","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0650","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1128\/JVI.74.5.2430-2437.2000","article-title":"The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious","volume":"74","author":"Panda","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0655","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.virusres.2013.07.020","article-title":"Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity","volume":"178","author":"Parvez","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0660","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-147-1-200707030-00005","article-title":"Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection","volume":"147","author":"Patra","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0665","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1099\/vir.0.049577-0","article-title":"Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1","volume":"94","author":"Perttil\u00e4","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0670","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: an open bioinformatics database and analysis resource for virology research","volume":"40","author":"Pickett","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0675","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1111\/j.1600-6143.2012.04200.x","article-title":"Chronic hepatitis e in heart transplant recipients","volume":"12","author":"Pischke","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2013.12.005_b0680","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2013.12.005_b0685","doi-asserted-by":"crossref","first-page":"10031","DOI":"10.1128\/JVI.00763-11","article-title":"Mutational analysis of the hypervariable region of hepatitis e virus reveals its involvement in the efficiency of viral RNA replication","volume":"85","author":"Pudupakam","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0690","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0264-410X(03)00100-2","article-title":"Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine","volume":"21","author":"Purcell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2013.12.005_b0695","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3201\/eid1712.110482","article-title":"Hepatitis E virus in rats, Los Angeles, California, USA","volume":"17","author":"Purcell","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0700","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1002\/chem.201003432","article-title":"Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments","volume":"17","author":"Rademacher","year":"2011","journal-title":"Chemistry"},{"key":"10.1016\/j.antiviral.2013.12.005_b0705","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3201\/eid1808.111659","article-title":"Novel hepatitis E virus in ferrets, The Netherlands","volume":"18","author":"Raj","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0710","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1021\/bi7016552","article-title":"The ORF3 protein of hepatitis E virus interacts with hemopexin by means of its 26 amino acid N-terminal hydrophobic domain II","volume":"47","author":"Ratra","year":"2008","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.antiviral.2013.12.005_b0715","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virol.2007.07.036","article-title":"Subcellular localization of hepatitis E virus (HEV) replicase","volume":"370","author":"Rehman","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.12.005_b0720","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.antiviral.2013.12.005_b0725","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0092-8674(90)90168-E","article-title":"Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis","volume":"63","author":"Ren","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2013.12.005_b0730","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1128\/JVI.02064-13","article-title":"The viral polymerase inhibitor 2\u2032-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model","volume":"87","author":"Rocha-Pereira","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0735","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s007050070093","article-title":"Expression of the hepatitis E virus ORF1","volume":"145","author":"Ropp","year":"2000","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0740","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virusres.2011.04.010","article-title":"Prior infection of pigs with a genotype 3 swine hepatitis E virus (HEV) protects against subsequent challenges with homologous and heterologous genotypes 3 and 4 human HEV","volume":"159","author":"Sanford","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0745","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/JVI.01986-08","article-title":"Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes","volume":"83","author":"Satheshkumar","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0750","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0755","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.97.24.13057","article-title":"Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2","volume":"97","author":"Schubert","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0760","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0049-3848(83)90010-5","article-title":"Anticoagulant and antiheparin activities of a pentosan polysulphate","volume":"31","author":"Scully","year":"1983","journal-title":"Thromb. Res."},{"key":"10.1016\/j.antiviral.2013.12.005_b0765","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1743-422X-3-38","article-title":"Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein","volume":"3","author":"Sehgal","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2013.12.005_b0770","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa061847","article-title":"Safety and efficacy of a recombinant hepatitis E vaccine","volume":"356","author":"Shrestha","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.12.005_b0775","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1073\/pnas.1018878108","article-title":"Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant","volume":"108","author":"Shukla","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0780","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1128\/JVI.00146-12","article-title":"Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination","volume":"86","author":"Shukla","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0785","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1099\/vir.0.045351-0","article-title":"Evolution of the hepatitis E virus hypervariable region","volume":"93","author":"Smith","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0790","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/JVI.02762-12","article-title":"Genetic variability and the classification of hepatitis E virus","volume":"87","author":"Smith","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0795","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/S0002-9270(00)02202-4","article-title":"Guillain-Barr\u00e9 syndrome with acute hepatitis E","volume":"95","author":"Sood","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0800","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1440-1746.2008.05677.x","article-title":"Detection of hepatitis E virus RNA and genotype in Bangladesh","volume":"24","author":"Sugitani","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0805","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1128\/JVI.01671-13","article-title":"Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in epstein-barr virus-infected cells","volume":"87","author":"Sun","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0810","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1743-422X-8-245","article-title":"Lack of processing of the expressed ORF1 gene product of hepatitis E virus","volume":"8","author":"Suppiah","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2013.12.005_b0815","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1074\/jbc.M509568200","article-title":"Enhanced alpha1 microglobulin secretion from Hepatitis E virus ORF3-expressing human hepatoma cells is mediated by the tumor susceptibility gene 101","volume":"281","author":"Surjit","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.12.005_b0820","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.virol.2004.10.006","article-title":"Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer","volume":"330","author":"Takahashi","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.12.005_b0825","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1128\/JCM.02002-09","article-title":"Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation","volume":"48","author":"Takahashi","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0830","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jhep.2003.12.026","article-title":"Consumption of wild boar linked to cases of hepatitis E","volume":"40","author":"Tamada","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0835","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1099\/vir.0.82535-0","article-title":"Development and evaluation of an efficient cell-culture system for Hepatitis E virus","volume":"88","author":"Tanaka","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0840","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JCM.00629-09","article-title":"Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5\/15F strain recovered from a fulminant hepatitis patient","volume":"47","author":"Tanaka","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0845","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chembiol.2005.01.006","article-title":"The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus","volume":"12","author":"Tanner","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0850","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/cb800193n","article-title":"Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction","volume":"3","author":"Tavassoli","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0855","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3201\/eid1601.090764","article-title":"Hepatitis E epidemic, Uganda","volume":"16","author":"Teshale","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.12.005_b0860","first-page":"173","article-title":"Hepatitis E virus infection in pregnancy in Ethiopia","volume":"31","author":"Tsega","year":"1993","journal-title":"Ethiop. Med. J."},{"key":"10.1016\/j.antiviral.2013.12.005_b0865","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1001\/jama.1990.03440240071018","article-title":"Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986\u20131987","volume":"263","author":"Vel\u00e1zquez","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0870","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2013-03-492363","article-title":"Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation","volume":"122","author":"Versluis","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2013.12.005_b0875","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0880","doi-asserted-by":"crossref","first-page":"8334","DOI":"10.1128\/JVI.01060-12","article-title":"Complete genome sequence of the genotype 4 hepatitis E virus strain prevalent in swine in Jiangsu Province, China, reveals a close relationship with that from the human population in this area","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0885","doi-asserted-by":"crossref","first-page":"32765","DOI":"10.1074\/jbc.M704418200","article-title":"Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B","volume":"282","author":"Watashi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.12.005_b0890","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1099\/vir.0.010561-0","article-title":"ORF3 protein of hepatitis E virus is essential for virion release from infected cells","volume":"90","author":"Yamada","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0895","doi-asserted-by":"crossref","first-page":"12986","DOI":"10.1073\/pnas.0903699106","article-title":"Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure","volume":"106","author":"Yamashita","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.12.005_b0900","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1128\/JVI.01205-10","article-title":"Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences","volume":"84","author":"Yu","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0905","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1128\/JVI.71.12.9045-9053.1997","article-title":"The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton","volume":"71","author":"Zafrullah","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0910","doi-asserted-by":"crossref","DOI":"10.3851\/IMP2567","article-title":"Faldaprevir (BI 201335), BI 207127 and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results","author":"Zeuzem","year":"2013","journal-title":"Antivir. Ther"},{"key":"10.1016\/j.antiviral.2013.12.005_b0915","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/jmv.21536","article-title":"A novel genotype of hepatitis E virus prevalent among farmed rabbits in China","volume":"81","author":"Zhao","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0920","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1099\/vir.0.019323-0","article-title":"Role of heat-shock protein 90 in hepatitis E virus capsid trafficking","volume":"91","author":"Zheng","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2013.12.005_b0925","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2013.12.005_b0930","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.vetmic.2013.06.021","article-title":"Infectivity of a genotype 4 hepatitis E virus cDNA clone by intrahepatic inoculation of laboratory rats","volume":"166","author":"Zhu","year":"2013","journal-title":"Vet. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:07:00Z","timestamp":1746090420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213003744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":187,"alternative-id":["S0166354213003744"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.12.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral strategies for hepatitis E virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}